Clinical trials: Mammography
Breast Neoplasms
In Vitro Study of the Liquid Biopsy Test System of the Diagnostic Value, in Women With Various Forms of Breast Cancer
The Study Objective is to evaluate the diagnostic efficacy of the liquid biopsy system versus the gold standard mammography (or MRI, or Ultrasound) diagnosis in patients with suspected breast cancer.
- Trial name
- ARNABreast (NCT04890340)
- Testing
- ARNA Breast
- Volunteers
- 500 people, healthy volunteers welcome
- Sponsor
- ARNA Genomics US Inc.
Breast Neoplasms
The Digital Breast Tomosynthesis Trial in Bergen
Compare synthetic mammography+digital breast tomosynthesis (SM+DBT) with digital mammography (DM) as a screening tool for women aged 50-69 years, invited to participate in the Norwegian Breast Cancer Screening Program at the…
- Trial name
- TOBE (NCT02835625)
- Testing
- Synthetic Mammography + Digital Breast Tomosynthesis, Digital mammography
- Where
- 2 sites in Norway
- Volunteers
- 29,453 people, healthy volunteers welcome
- Sponsor
- Norwegian Institute of Public Health
Breast Cancer
Stockholm Mammography Risk Stratified Trial
SMART is a Phase III, randomised, non-blinded screening trial. Women who consent to participate in SMART are randomised to either individualised screening or screening according to the Swedish National Breast Cancer Screening…
- Trial name
- SMART (NCT06270355)
- Testing
- Risk based screening
- Volunteers
- 70,000 people, healthy volunteers welcome
- Sponsor
- Karolinska Institutet
Mammography Screening
Effect of Distraction Technique on Pain and Anxiety During Mammography
One of the non-medical interventions aimed at reducing sensitization is the cognitive-behavioral approach, in which the individual's attention is shifted from a painful stimulus to an external stimulus.
- Trial name
- NCT06682026
- Testing
- listening to music or chatting
- Volunteers
- 62 people, healthy volunteers welcome
- Sponsor
- Hitit University
Breast Cancer
A Data Collection Study for the Evaluation of a Novel Infra-red Breast Imaging System for Risk Assessment
Three-dimensional functional Metabolic Imaging (3D MIRA) is a new infrared imaging technology using the Real Imager 8 (RI8) developed by Real Imaging.
- Trial name
- NCT02505698
- Where
- Israel
- Volunteers
- healthy volunteers welcome
- Sponsor
- Real Imaging Ltd.
Breast Cancer
Testing Conversation Aid in Practice
The goal of this research study is to develop and test a website to help primary care providers (PCPs) discuss the pros and cons of mammography with women aged 75 and older and to help participants make decisions about…
- Trial name
- NCT06011434
- Testing
- Mammography Screening Conversation Aid
- Where
- United States
- Volunteers
- 155 people, healthy volunteers welcome
- Sponsor
- Beth Israel Deaconess Medical Center
Breast Cancer
Breast Cancer Screening Intervention
Breast cancer is the most commonly occurring cancer and most common cause of cancer mortality among Korean American (KA) women, but mammography utilization among KA women remains suboptimal.
- Trial name
- NCT01525264
- Testing
- KIM-CHI, Healthy Wife Control Group
- Volunteers
- 434 people, healthy volunteers welcome
- Sponsor
- Jonsson Comprehensive Cancer Center
MR Mammography With Dotarem
Post Marketing Surveillance Study for Evaluation of Efficacy and Safety of Dotarem in Magnetic Resonance Mammography
Guerbet conducted a non-interventional post-marketing surveillance study on its Magnetic Resonance Imaging (MRI) contrast agent Dotarem (gadoteric acid/gadoterate meglumine) from September 2011 to December 2013.
- Trial name
- NCT03041298
- Testing
- MR mammography with Dotarem
- Volunteers
- 1,537 people, healthy volunteers welcome
- Sponsor
- Guerbet
Breast Cancer
Long-term Effects of Breast Cancer Treatment
The objective of this project is to generate evidence about quality of life related to side effects of treatment of women with screen-detected versus symptomatic breast cancer.
- Trial name
- NCT03877029
- Where
- Norway
- Volunteers
- 4,487 people, healthy volunteers welcome
- Sponsor
- Norwegian Institute of Public Health
Weight Loss, Breast Cancer Risk Factors
Addressing Modifiable Breast Cancer Risk Factors With Project CONECT
The objective of this protocol is to adapt and pilot test an existing lifestyle modification intervention for weight loss for women with overweight or obesity who have had a recent false positive mammography screen.
- Trial name
- NCT02871388
- Testing
- CONECT
- Where
- United States
- Volunteers
- 14 people, healthy volunteers welcome
- Sponsor
- Virginia Commonwealth University
Breast Cancer Screening
CESM ABMR Breast Cancer Screening Trial
This is a single institution, prospective screening trial of women at high risk for developing breast cancer, enriched with women with suspicious lesions on breast MRI which have been recommended for biopsy.
- Trial name
- NCT03517813
- Testing
- Contrast-enhanced Spectral Mammography (CESM)
- Where
- United States
- Volunteers
- 256 people, healthy volunteers welcome
- Sponsor
- University of Washington
Health Status Unknown
Questionnaires and Cognitive Assessments Following Mammography
This pilot research trial studies how well questionnaires and cognitive assessments work in tracking patient symptoms following mammography.
- Trial name
- NCT03412370
- Testing
- Cognitive Assessment, Questionnaire Administration
- Where
- United States
- Volunteers
- 6 people, healthy volunteers welcome
- Sponsor
- University of Southern California
Breast Neoplasms
Australian Screening Mammography Decision Aid Trial (ASMDAT)
The purpose of the study is to develop and evaluate a decision aid to assist women aged 70 years and over to make an informed choice about whether to continue screening mammography.
- Trial name
- NCT00247442
- Testing
- Decision aid
- Where
- Australia
- Volunteers
- 670 people, healthy volunteers welcome
- Sponsor
- University of Sydney
Breast Neoplasms
Early Detection of Breast Cancer
The TriNetra™ Breast test is intended for use as a breast cancer screening test that evaluates Circulating Tumor Cells (CTCs) associated with breast cancer.
- Trial name
- NCT06043661
- Where
- United States
- Volunteers
- 700 people, healthy volunteers welcome
- Sponsor
- Datar Cancer Genetics Inc
Breast Cancer Screening
Understanding Patient Experience and Preferences for the QT Scanner Compared to Mammography
This study aims to characterize patient experience, satisfaction and preference for use of the QT Scanner in comparison to mammography by directly engaging women who have experience with both technologies.
- Trial name
- NCT04057391
- Testing
- QT Scanner
- Where
- United States
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- QT Ultrasound LLC
Contrast Enhanced Mammography-guided Biopsy
Clinical Evaluation of CEM-guided Biopsy
CEM-guided biopsy is an optional accessory of Senographe Pristina intended to provide accurate location of lesions in the breast in three dimensions, using information obtained from Contrast Enhanced Mammography (CEM) images.
- Trial name
- NCT05250674
- Testing
- CEM-guided biopsy
- Where
- Spain
- Volunteers
- 66 people, healthy volunteers welcome
- Sponsor
- Parc de Salut Mar
Invasive Cancer, Ductal Carcinoma in Situ
The Mammography and Ultrasonography STudy for Breast Cancer Screening Effectiveness
Mammography screening has limited performance in young women or women with dense breasts although it is the only proven method for breast cancer screening that reduces the mortality.
- Trial name
- MUST-BE (NCT02909426)
- Testing
- Ultrasonography, Digital mammography
- Where
- South Korea
- Volunteers
- 11,880 people, healthy volunteers welcome
- Sponsor
- Soonchunhyang University Hospital
Mammographic Density, Abnormal Mammogram
KEEPS Mammographic Density And Breast Health Ancillary Study
Combined estrogen and progestin therapy has been shown to increase mammographic density and incidence of breast cancer in randomized trials.
- Trial name
- KEEPS MDBHAS (NCT02524561)
- Testing
- CEE pill, Estradiol patch, Active Progesterone
- Where
- United States
- Volunteers
- 517 people, healthy volunteers welcome
- Sponsor
- Brigham and Women's Hospital
Breast Cancer
A Randomized Trial of Letters From Family Physicians to Encourage Screening Mammography in Overdue Women
A randomized, double-blinded study conducted in British Columbia, Canada, where there is a publicly funded, organized screening program and screening mammography is recommended at 24-month intervals.
- Trial name
- NCT02660788
- Testing
- Standard Reminder Postcard, Family Physician Reminder Letter
- Where
- Canada
- Volunteers
- 5,498 people, healthy volunteers welcome
- Sponsor
- British Columbia Cancer Agency
Breast Neoplasms
Digital Breast Tomosynthesis Versus Digital Mammography: A National Multicenter Trial
The goal of this study is to determine the value of the new mammography technique called Digital Breast Tomosynthesis (DBT) compared to the current standard technique Digital Mammography for the early detection of Breast Cancer.
- Trial name
- NCT01524029
- Where
- 5 sites in Austria
- Volunteers
- 600 people, healthy volunteers welcome
- Sponsor
- Medical University of Vienna